KALA Insider Trading
Insider Ownership Percentage: 8.32%
Insider Buying (Last 12 Months): $1,999,999.96
Insider Selling (Last 12 Months): $255,095.17
KALA BIO Share Price & Price History
Current Price: $3.22
Price Change: ▼ Price Decrease of -0.05 (-1.53%)
As of 05/15/2025 05:00 PM ET
KALA BIO Insider Trading History
KALA BIO Institutional Trading History
Data available starting January 2016
KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Read More on KALA BIO
Volume
35,606 shs
Average Volume
93,874 shs
Market Capitalization
$20.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of KALA BIO?
Who are the major institutional investors of KALA BIO?
Which institutional investors are buying KALA BIO stock?
During the previous quarter, KALA stock was purchased by institutional investors including:
- AIGH Capital Management LLC
- Readystate Asset Management LP